Literature DB >> 27989715

Human Embryonic Stem Cells Do Not Change Their X Inactivation Status during Differentiation.

Sanjeet Patel1, Giancarlo Bonora1, Anna Sahakyan1, Rachel Kim1, Constantinos Chronis1, Justin Langerman1, Sorel Fitz-Gibbon2, Liudmilla Rubbi2, Rhys J P Skelton3, Reza Ardehali3, Matteo Pellegrini2, William E Lowry2, Amander T Clark2, Kathrin Plath4.   

Abstract

Applications of embryonic stem cells (ESCs) require faithful chromatin changes during differentiation, but the fate of the X chromosome state in differentiating ESCs is unclear. Female human ESC lines either carry two active X chromosomes (XaXa), an Xa and inactive X chromosome with or without XIST RNA coating (XiXIST+Xa;XiXa), or an Xa and an eroded Xi (XeXa) where the Xi no longer expresses XIST RNA and has partially reactivated. Here, we established XiXa, XeXa, and XaXa ESC lines and followed their X chromosome state during differentiation. Surprisingly, we found that the X state pre-existing in primed ESCs is maintained in differentiated cells. Consequently, differentiated XeXa and XaXa cells lacked XIST, did not induce X inactivation, and displayed higher X-linked gene expression than XiXa cells. These results demonstrate that X chromosome dosage compensation is not required for ESC differentiation. Our data imply that XiXIST+Xa ESCs are most suited for downstream applications and show that all other X states are abnormal byproducts of our ESC derivation and propagation method.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA methylation; X-chromosome dosage compensation; X-inactivation; Xi-erosion; Xist; human embryonic stem cells; human induced pluripotent stem cells; inactive X chromosome

Mesh:

Substances:

Year:  2016        PMID: 27989715      PMCID: PMC5214931          DOI: 10.1016/j.celrep.2016.11.054

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.995


  34 in total

1.  Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations.

Authors:  Christopher J Lengner; Alexander A Gimelbrant; Jennifer A Erwin; Albert Wu Cheng; Matthew G Guenther; G Grant Welstead; Raaji Alagappan; Garrett M Frampton; Ping Xu; Julien Muffat; Sandro Santagata; Doug Powers; C Brent Barrett; Richard A Young; Jeannie T Lee; Rudolf Jaenisch; Maisam Mitalipova
Journal:  Cell       Date:  2010-05-13       Impact factor: 41.582

2.  Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase.

Authors:  Oz Pomp; Oliver Dreesen; Denise Fong Mei Leong; Orit Meller-Pomp; Thong Teck Tan; Fan Zhou; Alan Colman
Journal:  Cell Stem Cell       Date:  2011-08-05       Impact factor: 24.633

3.  The dynamic changes of X chromosome inactivation during early culture of human embryonic stem cells.

Authors:  Pingyuan Xie; Qi Ouyang; Lizhi Leng; Liang Hu; Dehua Cheng; Yueqiu Tan; Guangxiu Lu; Ge Lin
Journal:  Stem Cell Res       Date:  2016-05-22       Impact factor: 2.020

4.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

5.  Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells.

Authors:  Carol B Ware; Linlin Wang; Brigham H Mecham; Lanlan Shen; Angelique M Nelson; Merav Bar; Deepak A Lamba; Derek S Dauphin; Brian Buckingham; Bardia Askari; Raymond Lim; Muneesh Tewari; Stanley M Gartler; Jean-Pierre Issa; Paul Pavlidis; Zhijun Duan; C Anthony Blau
Journal:  Cell Stem Cell       Date:  2009-04-03       Impact factor: 24.633

6.  Erosion of dosage compensation impacts human iPSC disease modeling.

Authors:  Shila Mekhoubad; Christoph Bock; A Sophie de Boer; Evangelos Kiskinis; Alexander Meissner; Kevin Eggan
Journal:  Cell Stem Cell       Date:  2012-05-04       Impact factor: 24.633

7.  Human Naive Pluripotent Stem Cells Model X Chromosome Dampening and X Inactivation.

Authors:  Anna Sahakyan; Rachel Kim; Constantinos Chronis; Shan Sabri; Giancarlo Bonora; Thorold W Theunissen; Edward Kuoy; Justin Langerman; Amander T Clark; Rudolf Jaenisch; Kathrin Plath
Journal:  Cell Stem Cell       Date:  2016-12-15       Impact factor: 25.269

8.  Histone variant macroH2A confers resistance to nuclear reprogramming.

Authors:  Vincent Pasque; Astrid Gillich; Nigel Garrett; John B Gurdon
Journal:  EMBO J       Date:  2011-05-06       Impact factor: 11.598

9.  Derivation of consensus inactivation status for X-linked genes from genome-wide studies.

Authors:  Bradley P Balaton; Allison M Cotton; Carolyn J Brown
Journal:  Biol Sex Differ       Date:  2015-12-30       Impact factor: 5.027

10.  Translating dosage compensation to trisomy 21.

Authors:  Jun Jiang; Yuanchun Jing; Gregory J Cost; Jen-Chieh Chiang; Heather J Kolpa; Allison M Cotton; Dawn M Carone; Benjamin R Carone; David A Shivak; Dmitry Y Guschin; Jocelynn R Pearl; Edward J Rebar; Meg Byron; Philip D Gregory; Carolyn J Brown; Fyodor D Urnov; Lisa L Hall; Jeanne B Lawrence
Journal:  Nature       Date:  2013-07-17       Impact factor: 49.962

View more
  41 in total

1.  Memories of an X-chromosome.

Authors:  Ismael Lamas-Toranzo; Eva Pericuesta; Pablo Bermejo-Álvarez
Journal:  Stem Cell Investig       Date:  2017-04-07

2.  New Advances in Human X chromosome status from a Developmental and Stem Cell Biology.

Authors:  Benjamin Patterson; Yoshiaki Tanaka; In-Hyun Park
Journal:  Tissue Eng Regen Med       Date:  2017-11-22       Impact factor: 4.169

Review 3.  X-chromosome dosage as a modulator of pluripotency, signalling and differentiation?

Authors:  Edda G Schulz
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-11-05       Impact factor: 6.237

Review 4.  Regulation of X-chromosome dosage compensation in human: mechanisms and model systems.

Authors:  Anna Sahakyan; Kathrin Plath; Claire Rougeulle
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-11-05       Impact factor: 6.237

5.  X-chromosome activity in naive human pluripotent stem cells-are we there yet?

Authors:  Shafqat A Khan; Pauline N C B Audergon; Bernhard Payer
Journal:  Stem Cell Investig       Date:  2017-06-13

6.  Germline competency of human embryonic stem cells depends on eomesodermin.

Authors:  Di Chen; Wanlu Liu; Anastasia Lukianchikov; Grace V Hancock; Jill Zimmerman; Matthew G Lowe; Rachel Kim; Zoran Galic; Naoko Irie; M Azim Surani; Steven E Jacobsen; Amander T Clark
Journal:  Biol Reprod       Date:  2017-01-01       Impact factor: 4.285

Review 7.  The Role of Xist in X-Chromosome Dosage Compensation.

Authors:  Anna Sahakyan; Yihao Yang; Kathrin Plath
Journal:  Trends Cell Biol       Date:  2018-06-14       Impact factor: 20.808

Review 8.  Epigenetic aberrations in human pluripotent stem cells.

Authors:  Shiran Bar; Nissim Benvenisty
Journal:  EMBO J       Date:  2019-05-14       Impact factor: 11.598

Review 9.  The Ambivalent Role of lncRNA Xist in Carcinogenesis.

Authors:  Yung-Kang Chen; Yun Yen
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

Review 10.  Human X chromosome inactivation and reactivation: implications for cell reprogramming and disease.

Authors:  Irene Cantone; Amanda G Fisher
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-11-05       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.